Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteria
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/213959 |
Resumo: | The study aimed to estimate and compare the prevalence and type of potentially inappropriate medications (PIMs) and potential prescribing omissions (PPOs) between the STOPP/START original (v1) and updated version (v2) among older patients in various settings, as well as associated factors. The study included 440 patients attending a community pharmacy, 200 outpatients and 140 nursing home users. An increase in the prevalence of STOPP v2 (57.9%) compared to v1 (56.2%) was not statistically significant in the total sample and within each setting (p>0.05). A decrease in the prevalence of START v1 (55.8%) to v2 (41.2%) was statistically significant (p<0.001) in the total sample and within each setting (p<0.05). Drug indication (32.9%) and fall-risk medications (32.2%) were most commonly identified for STOPP v2, while cardiovascular system criteria (30.5%) were the most frequently detected for START v2. The number of medications was the strongest predictor for both STOPP v1 and v2, with odds ratio values of 1.35 and 1.34, respectively. Patients’ characteristics associated with the occurrence of STOPP and START criteria were identified. According to both STOPP/START versions, the results indicate a substantial rate of potentially inappropriate prescribing among elderly patients. The prevalence of PIMs was slightly higher with the updated version, while the prevalence of PPOs was significantly lower. |
id |
USP-31_c17d7891ac39ede228ea031b1ecca529 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/213959 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteriaGeriatricsHealth services for the agedPotentially inappropriate medication listDrug utilizationPrevalenceThe study aimed to estimate and compare the prevalence and type of potentially inappropriate medications (PIMs) and potential prescribing omissions (PPOs) between the STOPP/START original (v1) and updated version (v2) among older patients in various settings, as well as associated factors. The study included 440 patients attending a community pharmacy, 200 outpatients and 140 nursing home users. An increase in the prevalence of STOPP v2 (57.9%) compared to v1 (56.2%) was not statistically significant in the total sample and within each setting (p>0.05). A decrease in the prevalence of START v1 (55.8%) to v2 (41.2%) was statistically significant (p<0.001) in the total sample and within each setting (p<0.05). Drug indication (32.9%) and fall-risk medications (32.2%) were most commonly identified for STOPP v2, while cardiovascular system criteria (30.5%) were the most frequently detected for START v2. The number of medications was the strongest predictor for both STOPP v1 and v2, with odds ratio values of 1.35 and 1.34, respectively. Patients’ characteristics associated with the occurrence of STOPP and START criteria were identified. According to both STOPP/START versions, the results indicate a substantial rate of potentially inappropriate prescribing among elderly patients. The prevalence of PIMs was slightly higher with the updated version, while the prevalence of PPOs was significantly lower.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2023-07-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/21395910.1590/s2175-97902023e22549Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e22549Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023); e22549Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e225492175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/213959/196162Copyright (c) 2023 Brazilian Journal of Pharmaceutical Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessJovanović, MarijaKovačević , Milena Catić-Đorđević, Aleksandra Ćulafić, Milica Stefanović, Nikola Mitić, Branka Vučićević, Katarina Kovačević, Sandra Vezmar Veličković-Radovanović, Radmila Miljković, Branislava2024-08-06T11:49:33Zoai:revistas.usp.br:article/213959Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2024-08-06T11:49:33Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteria |
title |
Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteria |
spellingShingle |
Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteria Jovanović, Marija Geriatrics Health services for the aged Potentially inappropriate medication list Drug utilization Prevalence |
title_short |
Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteria |
title_full |
Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteria |
title_fullStr |
Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteria |
title_full_unstemmed |
Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteria |
title_sort |
Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteria |
author |
Jovanović, Marija |
author_facet |
Jovanović, Marija Kovačević , Milena Catić-Đorđević, Aleksandra Ćulafić, Milica Stefanović, Nikola Mitić, Branka Vučićević, Katarina Kovačević, Sandra Vezmar Veličković-Radovanović, Radmila Miljković, Branislava |
author_role |
author |
author2 |
Kovačević , Milena Catić-Đorđević, Aleksandra Ćulafić, Milica Stefanović, Nikola Mitić, Branka Vučićević, Katarina Kovačević, Sandra Vezmar Veličković-Radovanović, Radmila Miljković, Branislava |
author2_role |
author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Jovanović, Marija Kovačević , Milena Catić-Đorđević, Aleksandra Ćulafić, Milica Stefanović, Nikola Mitić, Branka Vučićević, Katarina Kovačević, Sandra Vezmar Veličković-Radovanović, Radmila Miljković, Branislava |
dc.subject.por.fl_str_mv |
Geriatrics Health services for the aged Potentially inappropriate medication list Drug utilization Prevalence |
topic |
Geriatrics Health services for the aged Potentially inappropriate medication list Drug utilization Prevalence |
description |
The study aimed to estimate and compare the prevalence and type of potentially inappropriate medications (PIMs) and potential prescribing omissions (PPOs) between the STOPP/START original (v1) and updated version (v2) among older patients in various settings, as well as associated factors. The study included 440 patients attending a community pharmacy, 200 outpatients and 140 nursing home users. An increase in the prevalence of STOPP v2 (57.9%) compared to v1 (56.2%) was not statistically significant in the total sample and within each setting (p>0.05). A decrease in the prevalence of START v1 (55.8%) to v2 (41.2%) was statistically significant (p<0.001) in the total sample and within each setting (p<0.05). Drug indication (32.9%) and fall-risk medications (32.2%) were most commonly identified for STOPP v2, while cardiovascular system criteria (30.5%) were the most frequently detected for START v2. The number of medications was the strongest predictor for both STOPP v1 and v2, with odds ratio values of 1.35 and 1.34, respectively. Patients’ characteristics associated with the occurrence of STOPP and START criteria were identified. According to both STOPP/START versions, the results indicate a substantial rate of potentially inappropriate prescribing among elderly patients. The prevalence of PIMs was slightly higher with the updated version, while the prevalence of PPOs was significantly lower. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-07-03 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/213959 10.1590/s2175-97902023e22549 |
url |
https://www.revistas.usp.br/bjps/article/view/213959 |
identifier_str_mv |
10.1590/s2175-97902023e22549 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/213959/196162 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2023 Brazilian Journal of Pharmaceutical Sciences https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2023 Brazilian Journal of Pharmaceutical Sciences https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e22549 Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023); e22549 Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e22549 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1824325293320437760 |